Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand

AAPS PharmSci

Volumn 1, Issue 2, 1999, Pages 39-45

  Lan, Ruoxi ^a   Lu, Qian ^a   Fan, Pusheng ^a   Gatley, John ^b   Volkow, Nora D ^b   Fernando, Susanthi R ^c   Pertwee, Roger ^c   Makriyannis, Alexandras ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

AM281; Cannabinoid CB1 receptor; Cannabinoid receptor antagonist; CB1 selective ligand; SPECT image

Indexed keywords

EID: 33947267195     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: 10.1208/ps010204     Document Type: Article

References (25)

1. Martin BR. Cellular effects of cannabinoids. Pharmacol Rev. 1986;38:45-74.
2. Devane WA, Dysarz FA 3d, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34:605-613.
3. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature (London) 1993;365:61-65.
4. Barth F, Casellas P, Congy C, Martinez S, Rinaldi M, Anne-Archard G. Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present. US Patent 5,624,941 Apr. 29, 1997.
5. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Breliere JC, Le Fur G. SR141716A, A potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 1994;350:240-244.
6. Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Breliere JC, Le Fur G. Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 1995;56:1941-1947.
7. Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P. Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem. 1996;271:6941-6946.
8. Rinaldi-Carmona M, Pialot F, Congy C, Redon E, Barth F, Bachy A, Breliere JC, Soubrié P, Le Fur G. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci. 1996;58:1239-1247.
9. 1 receptors. Eur J Pharmacol. 1996;307:331-338.
10. Lan R, Galley SJ, Makriyannis A. Preparation of iodine-123 labeled AM251: a potential SPECT radioligand for the brain cannabinoid CB1 receptor. J Label Compds Radiopharma 1996;38:875-881.
11. Galley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci. 1997;61:PL191-197.
12. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, DeCosla BR, Rice KC. Cannabinoid receptor localization in brain. Proc Nail Acad Sci. 1990;87:1932-1936.
13. Herkenham M, Lynn AB, Johnson MR, Melvin LS, DeCosta BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro auloradiographic study. J Neurosci. 1991;11:563-583.
14. Galley SJ, Lan R, Volkow ND, Pappas N, King P, Wong CT, Gifford AN, Pyatt B, Dewey SL, Makriyannis A. Imaging the brain marijuana receptor: Development of a radioligand that binds to cannabinoid CB1 receptors in vivo. J Neurochem. 1998; 70:417-23.
15. Hanson RN, El-Wakil H. Eleclrophilic destannylation: stereospecific introduction of electrophiles at the 21 position of (17α)-19-Norpregna-1,3,5(10),20-tetraene-3-17β-diols. J Org Chem. 1987;52:3687-3688.
16. Pertwee, RG, Fernando, SR, Nash, JE, Coutts, AA. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br J Pharmacol. 1996;118:2199-2205.
17. Gifford AN, Tang Y, Galley SJ, Volkow ND, Lan R, Makriyannis A. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acelylcholine release from rat brain slices. Neurosci Lett. 1997;238:84-86.
18. Drake DJ, Jensen RS, Busch-Peterson J, Kawakami JK, Fernandez-Garcia MC, Fan P, Makriyannis A, Tius MA. Classical/nonclassical hydrid cannabinoids: southern aliphatic chain-funclionalized C-6β methyl, ethyl, and propyl analogues. J Med Chem. 1998;41:3596-3608.
19. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem. 1994;37:1889-1893.
20. Dodd PR, Hardy JA, Oakley AE, Edwardson JA, Perry EK, Delaunoy JP. A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res. 1981;226:107-118.
21. 8-THC: a novel photoaffinity label for the cannabinoid receptor. J Med Chem. 1992;35:3076-3079.
22. 50) of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099-3108.
23. Coutts AA, Pertwee RG. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig Myenteric plexus. Br J Pharmacol. 1997;21:1557-1566.
24. Tallarida RJ, Cowan A, Adler MW. pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 1979;25:637-654.
25. Colquhoun D. Lectures on Biostatistics. Oxford: Oxford University Press; 1971.